ABX
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABX, covering 2016-02-23 to 2024-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients [Phase 2]